New Additions to Drugs.com for 2010
The following 63 drugs were added to the Drugs.com database in 2010.
Safyral
Dec 30, 2010 - Safyral (drospirenone, ethinyl estradiol and levomefolate calcium) is an estrogen/progestin combined oral contraceptive containing a folate, indicated for use by women to prevent pregnancy, and to raise folate levels in women who choose to use an oral contraceptive for contraception.
Amturnide
Dec 29, 2010 - Amturnide (aliskiren, amlodipine and
hydrochlorothiazide) is a direct renin
inhibitor, calcium channel blocker and diuretic combination for the treatment of high blood pressure.
Gablofen
Nov 30, 2010 - Gablofen (baclofen) is a gamma-aminobutyric acid (GABA) ergic agonist indicated for use in the management of severe spasticity.
Xgeva
Nov 28, 2010 - Xgeva (denosumab) is a RANK ligand (RANKL) inhibitor indicated for the prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors. Xgeva is also indicated for treatment giant cell tumor of bone and for the treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy.
Axiron
Nov 24, 2010 - Axiron (testosterone) is an androgen indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.
Halaven
Nov 15, 2010 - Halaven (eribulin mesylate) is a microtubule inhibitor indicated for the treatment of patients with metastatic breast cancer and liposarcoma.
Egrifta
Nov 11, 2010 - Egrifta (tesamorelin) is a synthetic analogue of growth hormone releasing factor (GRF) for the treatment of excess abdominal fat in HIV patients with lipodystrophy.
Ofirmev
Nov 8, 2010 - Ofirmev (acetaminophen) is an intravenous analgesic product for the treatment of acute pain and fever in adults and children.
Nuedexta
Nov 7, 2010 - Nuedexta (dextromethorphan and quinidine) is a first-in-class dual action glutamate inhibitor indicated for the treatment of pseudobulbar affect.
Kombiglyze XR
Nov 7, 2010 - Kombiglyze XR (saxagliptin and metformin) is a once-daily fixed dose combination of the dipeptidyl peptidase-4 (DPP-4) inhibitor Onglyza (saxagliptin) and extended release metformin for the treatment of type 2 diabetes.
Teflaro
Nov 1, 2010 - Teflaro (ceftaroline fosamil) is a cephalosporin antibacterial indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
Latuda
Oct 31, 2010 - Latuda (lurasidone) is an atypical antipsychotic agent for the treatment of
schizophrenia and bipolar depression.
Lo Loestrin Fe
Oct 25, 2010 -
Bromday
Oct 20, 2010 - Bromday (bromfenac ophthalmic solution) is a once-daily ocular nonsteroidal anti-inflammatory agent for the treatment of postoperative inflammation and
reduction of ocular pain in patients who have undergone cataract surgery.
Pradaxa
Oct 20, 2010 - Pradaxa (dabigatran etexilate) is a direct thrombin inhibitor indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
Sorilux
Oct 18, 2010 - Sorilux (calcipotriene) Foam is a vitamin D analog indicated for the topical treatment of plaque psoriasis in patients aged 18
years and older.
Aridol
Oct 18, 2010 - Aridol (mannitol inhalation powder) is a bronchial challenge test designed to help in the correct diagnosis and assessment of asthma.
Atelvia
Oct 11, 2010 - Atelvia (risedronate sodium) is a bisphosphonate in a delayed-release formulation
for treatment of postmenopausal osteoporosis.
Kapvay
Oct 4, 2010 - Kapvay (clonidine hydrochloride) is a centrally acting alpha2-adrenergic agonist indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy or as adjunctive therapy to stimulant medications.
Beyaz
Sep 27, 2010 - (drospirenoneand ethinyl estradiol) Tablets Treatment for Prevention of Pregnancy
Gilenya
Sep 22, 2010 - Gilenya (fingolimod) is a sphingosine 1-phosphate receptor modulator indicated for the treatment of patients with relapsing forms of multiple sclerosis.
Krystexxa
Sep 16, 2010 - Krystexxa (pegloticase) is a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy.
Tekamlo
Aug 29, 2010 - Tekamlo (aliskiren and amlodipine) is a direct renin inhibitor and calcium channel
blocker combination indicated for the treatment of high blood pressure.
Suprep
Aug 23, 2010 - Suprep (sodium sulfate, potassium sulfate, magnesium sulfate) is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults.
Xeomin
Aug 9, 2010 - Xeomin (incobotulinumtoxinA) is a botulinum toxin type A for the treatment of adults with cervical dystonia, blepharospasm, glabellar lines, upper limb spasticity, and excessive drooling.
Lastacaft
Aug 9, 2010 - Lastacaft (alcaftadine ophthalmic solution) is a topical H1 histamine receptor antagonist indicated for the relief of itching associated with allergic conjunctivitis.
Cuvposa
Jul 29, 2010 - Cuvposa (glycopyrrolate) oral solution is an anticholinergic for the treatment of chronic severe drooling caused by neurologic
disorders in children.
Tribenzor
Jul 26, 2010 - Tribenzor (amlodipine, hydrochlorothiazide and olmesartan) is a three-in-one combination product taken once-daily for the treatment of hypertension.
Veltin
Jul 21, 2010 - Veltin Gel (clindamycin phosphate and tretinoin) is a combination of an antibiotic and a retinoid indicated for the topical treatment of acne vulgaris.
Zuplenz
Jul 13, 2010 - Zuplenz is an oral soluble film formulation of ondansetron for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting.
Glassia
Jul 11, 2010 - Glassia is an alpha1-proteinase inhibitor that is indicated for chronic augmentation and maintenance therapy in adults with emphysema due to congenital deficiency of alpha1-proteinase inhibitor (Alpha1-PI), also known as alpha1antitrypsin deficiency.
Alsuma
Jul 11, 2010 - Alsuma (sumatriptan injection) is a triptan indicated for the acute treatment of migraine attacks and cluster headache episodes.
Butrans
Jul 2, 2010 - Butrans (buprenorphine) is a transdermal opioid analgesic for the management of moderate to severe chronic pain in patients
requiring continuous treatment for an extended period of time.
Dulera
Jun 24, 2010 - Dulera (mometasone furoate and formoterol fumarate) is a combination product containing a corticosteroid and a long-acting beta2-adrenergic agonist indicated for the treatment of asthma in patients 12 years of age and older.
Staxyn
Jun 22, 2010 - Staxyn (vardenafil) is a phosphodiesterase type 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction.
Cysview
Jun 20, 2010 - Cysview (hexaminolevulinate HCl) is an optical imaging agent indicated for use in the cystoscopic detection of non-muscle invasive papillary cancer of the bladder.
Jevtana
Jun 17, 2010 - Jevtana (cabazitaxel) is a microtubule inhibitor indicated in combination with prednisone for treatment of patients with hormone-refractory metastatic prostate cancer.
Jalyn
Jun 15, 2010 - Jalyn is a combination of dutasteride (5α-reductase inhibitor) and tamsulosin (alpha-adrenergic antagonist) indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate.
Prolia
Jun 2, 2010 - Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every 6 months by a healthcare provider to treat osteoporosis in postmenopausal women at high risk for fracture, to treat glucocorticoid-induced osteoporosis, and to increase bone mass in men and women receiving certain treatments.
Lumizyme
May 31, 2010 - Lumizyme (alglucosidase alfa) is a lysosomal glycogen-specific enzyme indicated for patients 8 years and older with late (non-infantile) onset Pompe disease.
Zymaxid
May 30, 2010 - Zymaxid (gatifloxacin ophthalmic) is a fluoroquinolone anti-infective
indicated for the treatment of bacterial conjunctivitis.
Sprix Nasal Spray
May 30, 2010 - Sprix (ketorolac tromethamine) is an intranasal analgesic for the management of acute moderate to severe pain.
Natazia
May 7, 2010 - Natazia (estradiol valerate/dienogest) is an estrogen/progestin combination oral contraceptive indicated for use by women to prevent pregnancy.
Vimovo
May 3, 2010 - Vimovo is a combination of the pain reliever naproxen (NSAID) and esomeprazole magnesium (proton pump inhibitor) indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, and
ankylosing spondylitis, and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.
Provenge
Apr 29, 2010 - Provenge (sipuleucel-T) is an autologous cellular immunotherapy indicated for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.
Zortress
Apr 26, 2010 - Zortress (everolimus) is an oral inhibitor of the mTOR pathway indicated for the prevention of rejection of kidney transplants in adult patients at low-to-moderate immunologic risk.
Oravig
Apr 26, 2010 - Oravig (miconazole) is a mucoadhesive buccal azole antifungal therapy indicated for the local treatment of oropharyngeal candidiasis in adults.
Pancreaze
Apr 22, 2010 - Pancreaze (pancrelipase) is a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions.
Asclera
Apr 4, 2010 - Asclera (polidocanol) is a sclerosing agent used for the treatment of varicose veins.
Zyclara
Mar 31, 2010 - Zyclara (imiquimod) is an immune response modifier indicated for the topical treatment of actinic keratoses.
Carbaglu
Mar 31, 2010 - Carbaglu (carglumic acid) is a carbamoyl phosphate synthetase 1 (CPS 1) activator indicated for the treatment of hyperammonemia due to the deficiency of the hepatic enzyme N-acetylglutamate synthase (NAGS).
Silenor
Mar 23, 2010 - Silenor (doxepin) is a low-dose oral tablet
formulation of the H1 receptor antagonist doxepin indicated for the treatment of insomnia characterized by difficulties with sleep maintenance.
Hizentra
Mar 8, 2010 - Hizentra is an Immune Globulin Subcutaneous (Human) (IGSC), 20% Liquid indicated for the treatment of primary immunodeficiency.
Exalgo
Mar 3, 2010 - Exalgo (hydromorphone) is a once-a-day extended release opioid formulation for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
VPRIV
Feb 28, 2010 - VPRIV (velaglucerase alfa) is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy for pediatric and adult patients with Type 1 Gaucher disease.
Prevnar 13
Feb 25, 2010 - Prevnar 13 (pneumococcal 13-valent conjugate vaccine) is a vaccine indicated for active immunization against invasive pneumococcal disease.
Menveo
Feb 25, 2010 - Menveo (Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine) is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.
Cayston
Feb 23, 2010 - Cayston (aztreonam lysine for inhalation) is an inhaled anti-pseudomonal therapy for people with cystic fibrosis (CF) who have pulmonary Pseudomonas
aeruginosa infection.
Xiaflex
Feb 10, 2010 - Xiaflex (collagenase clostridium histolyticum) is a collagenase product for the treatment of Dupuytren's contracture, a condition that affects the connective tissue that lies beneath the skin in the palm.
Oleptro
Feb 10, 2010 - Oleptro (trazodone) is a once-daily serotonin antagonist reuptake inhibitor (SARI) formulation for the treatment of major depressive disorder (MDD) in adults.
Victoza
Jan 26, 2010 - Victoza (liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.
Ampyra
Jan 22, 2010 - Ampyra (dalfampridine) is an oral potassium channel blocker indicated to improve walking ability in people with multiple sclerosis.
Actemra
Jan 11, 2010 - Actemra (tocilizumab) is a humanized interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis (SJIA), polyarticular juvenile idiopathic arthritis (PJIA), giant cell arteritis; cytokine release syndrome, and systemic sclerosis-associated interstitial lung disease. Learn about side effects, interactions and indications.